share_log

Maxim Group Maintains Buy on Heart Test Laboratories, Lowers Price Target to $3

Benzinga Real-time News ·  Dec 19, 2022 21:36

Maxim Group analyst Allen Klee maintains Heart Test Laboratories (NASDAQ:HSCS) with a Buy and lowers the price target from $8 to $3.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment